Am J Transplant, Volume 20, Suppl 3 Archives - Page 55 of 223 - ATC Abstracts

2020 American Transplant Congress
Lose Weight to Donate Program: Preliminary Results of a Program Intended to Optimize Obese Living Donor Liver Candidates
J. Rose¹, T. Seay², A. Pesch³, P. Vargas⁴, S. Pelletier⁴, J. Oberholzer⁴, C. Argo⁵, N. Goldaracena⁴
¹School of Medicine, University of Virginia Health System, Charlottesville, VA, ²Division of Transplantation, University of Virginia Health System, Charlottesville, VA, ³Radiology Department, University of Virginia Health System, Charlottesville, VA, ⁴Department of Surgery, Division of Transplantation, University of Virginia Health System, Charlottesville, VA, ⁵Department of Medicine-Gastroenterology, University of Virginia Health System, Charlottesville, VA
*Purpose: Living donation (LD) can alleviate organ shortage, but is limited by obesity compromising organ quality and donor safety. This study intends to assess the…
2020 American Transplant Congress
Older Livers Should Not Be Utilized in Pediatric Liver Transplantation
M. MacConmara, C. Feizpour, A. Aqul, D. Desai, P. Vagefi, S. Hanish, L. DeGregorio, C. S. Hwang
UT Southwestern, Dallas, TX
*Purpose: Organ scarcity in liver transplantation has required expansion of the acceptable criteria used for donor selection. The utilization of older donors (>60 years) has…
2020 American Transplant Congress
Successful Use of Tedizolid for the Treatment of Nocardiosis in Transplant Recipients
R. Odrobina¹, B. Tritle², C. A.Gomez¹
¹Division of Infectious Diseases, University of Utah, Salt Lake City, UT, ²Department of Pharmacy, University of Utah, Salt Lake City, UT
*Purpose: Nocardiosis is an opportunistic infection occasionally seen after solid organ (SOT) and hematopoietic stem-cell transplantation. Treatment is challenging due to the limited number of…
2020 American Transplant Congress
Multi-Organ Procurement Organization Review of the Impact of Reactive Anti-HCV and HCV NAT Results
C. C. Muse, C. A. Hostetler, R. A. Squires, J. P. Orlowski
LifeShare Transplant Donor Services of Oklahoma, Oklahoma City, OK
*Purpose: Previously a single organ procurement organization (OPO) reviewed data from a 15 month cohort (1/1/2016 to 3/31/17) and concluded that donors who tested positive…
2020 American Transplant Congress
Hematopoietic Cell Transplantation and Solid Organ Transplantation: Outcomes of Sequential Transplantation in the United States
M. Gupta¹, M. Levine², D. Porter², R. Brazauskas³, S. Bo-Subait⁴, R. Phelan³, M. Battiwalla⁵, D. Buchbinder⁶, B. Hamilton⁷, B. Shaw³, P. Abt²
¹University of Kentucky, Lexington, KY, ²University of Pennsylvania, Philadelphia, PA, ³Medical College of Wisconsin, Milwaukee, WI, ⁴CIBMTR, NMDP, Minneapolis, MN, ⁵Sarah Cannon Blood Cancer Network, Nashville, TN, ⁶Children's Hospital of Orange County, Orange, CA, ⁷Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
*Purpose: Survival after solid organ transplantation(SOT) and hematopoietic cell transplantation(HCT) has steadily risen. Despite these improvements, SOT recipients may develop conditions requiring HCT, and HCT…
2020 American Transplant Congress
Association between Education and Waitlist Mortality, Access to Transplant, and Post-Transplant Survival among Patients with Alcohol-Associated Liver Disease
A. T. Strauss, J. Motter, D. Segev, A. Massie, T. Purnell, J. Hamilton, A. Gurakar, A. Cameron, J. Garonzik-Wang
Johns Hopkins University, Baltimore, MD
*Purpose: Alcohol-associated liver disease (ALD) is the leading indication for liver transplant (LT) and these patients have been shown to have worse outcomes compared to…
2020 American Transplant Congress
Evaluation of Apixaban Usage in Solid Organ Transplant Patients with Renal Impairment
L. Rakouki, R. Yau, C. Tunwar
Pharmacy, CHI St. Luke's Health-Baylor St. Luke's Medical Center, Houston, TX
*Purpose: There remains a gap in the literature for apixaban dosing recommendations for treatment of deep vein thrombosis (DVT) or pulmonary embolism (PE) in special…
2020 American Transplant Congress
Public Information Needs about VCA Donation and Transplantation in the United States
H. Sung¹, A. Ferzola¹, J. Uriarte², N. Anderson², C. Cooney¹, G. Brandacher¹, E. Gordon², M. Henderson¹
¹Johns Hopkins University, Baltimore, MD, ²Northwestern University, Evanston, IL
*Purpose: Vascularized Composite Allotransplantation (VCA) involves transplantation of multiple tissues (e.g., skin, muscle, bone, nerves, blood vessels, etc.) as a structural unit from a donor…
2020 American Transplant Congress
Membrane Expression of CD163 and CD206 by Blood Monocytes is Upregulated in Kidney Allograft Recipients
I. Striz, L. Curnova, V. Svachova, M. Fialova, M. Novotny, O. Viklicky
Institute for Clinical and Experimental Medicine, Prague, Czech Republic
*Purpose: Blood monocytes differentiating into tissue macrophages or dendritic cells are involved in multiple immune responses including reactions to the transplanted allograft. Peripheral monocytes can…
2020 American Transplant Congress
Two Pilot Studies Exploring the Diagnostic and Predictive Potential of Serum LAG3 and FGL1 in Kidney Transplant Recipients
Y. Li¹, L. Yan¹, Y. Li¹, C. Yang¹, Z. Wan¹, Y. An¹, Y. Bai¹, L. Wang¹, Y. Shi²
¹Department of Laboratory Medicine, West China Hospital, Chengdu, China, ²Department of Nephrology, West China Hospital, Chengdu, China
*Purpose: Lymphocyte activation gene 3 (LAG3), an immune checkpoint, plays an important role in the negative regulation of immune response and the induction of immune…